Recommended Concentration of Diclofenac Gel for Adults
For adults, diclofenac sodium 3% gel is the recommended concentration for treating actinic keratosis, while diclofenac sodium 1% gel is the recommended concentration for pain management applications. 1
Diclofenac Gel Concentrations by Indication
For Actinic Keratosis Treatment
- 3% diclofenac sodium gel formulated with 2.5% hyaluronic acid 2, 1
- Applied twice daily for 60-90 days
- Achieves 70% clearance of target lesions compared to 44% with vehicle alone
- Causes less intense local skin reactions than alternative treatments
For Pain Management
- 1% diclofenac sodium gel for musculoskeletal pain 3
- FDA-approved commercial preparation
- Significantly lower systemic exposure compared to oral diclofenac
- Applied 4 times daily to affected area
Efficacy and Safety Considerations
Systemic Absorption
- Topical 1% diclofenac gel has 5-17 fold lower systemic exposure compared to oral diclofenac 3
- The extent of absorption depends more on:
Safety Profile
- Main side effects of diclofenac gel include:
- Higher concentrations (5-10%) used in compounded preparations may lead to increased systemic absorption and potential adverse effects 4
Important Clinical Considerations
Formulation Matters
- The presence of hyaluronic acid in the 3% gel enhances drug delivery to the target tissue for actinic keratosis treatment 1
- Different gel bases affect permeability and absorption rates 4
Application Guidelines
- For pain management: Apply to affected area 4 times daily 3
- For actinic keratosis: Apply twice daily for 60-90 days 1, 5
- Extending treatment beyond 90 days provides minimal additional benefit for actinic keratosis 1
Caution with Compounded Preparations
- Compounded diclofenac gels often range from 1% to 10% (or higher) 4
- Higher concentrations (>3%) have not been thoroughly evaluated for safety
- Increased concentration may lead to higher systemic exposure and potential adverse effects 4
While compounded preparations with concentrations of 5-10% exist, they lack the same level of safety data as the FDA-approved 1% (for pain) and 3% (for actinic keratosis) formulations. For maximum safety and efficacy, clinicians should use the FDA-approved concentrations appropriate for the specific indication.